close التداول ينطوي على مخاطر الاستثمارات تنطوي على مخاطر وليست مناسبة لجميع المستثمرين. العقود مقابل الفروقات هي أدوات معقدة وتنطوي على مخاطر عالية لخسارة الأموال بسرعة بسبب الرافعة المالية.
Change languageالعربية
Dashboard

LLY

747.85

-0.07%↓

UNH

590.82

-1.04%↓

JNJ

155.2

-0.15%↓

NVO

105.18

+2.52%↑

ABBV

177.14

+3.17%↑

LLY

747.85

-0.07%↓

UNH

590.82

-1.04%↓

JNJ

155.2

-0.15%↓

NVO

105.18

+2.52%↑

ABBV

177.14

+3.17%↑

LLY

747.85

-0.07%↓

UNH

590.82

-1.04%↓

JNJ

155.2

-0.15%↓

NVO

105.18

+2.52%↑

ABBV

177.14

+3.17%↑

LLY

747.85

-0.07%↓

UNH

590.82

-1.04%↓

JNJ

155.2

-0.15%↓

NVO

105.18

+2.52%↑

ABBV

177.14

+3.17%↑

LLY

747.85

-0.07%↓

UNH

590.82

-1.04%↓

JNJ

155.2

-0.15%↓

NVO

105.18

+2.52%↑

ABBV

177.14

+3.17%↑

Home・Stock List・Intellia Therapeutics Inc
Search

Intellia Therapeutics Inc

Closed

Sector Healthcare

14.29 3.63

Strong Buy

Price update ٢٢ نوفمبر ٢٠٢٤، ٠٨:٥٩ م UTC

BuySell

Overview

Share price change

24h

Current

Min

14.1

Max

14.36

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+260.35 upside

Dividends

By Dow Jones

Next Earnings

٢٠ فبراير ٢٠٢٥

News Sentiment

By Acuity

50%

50%

176 / 392 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

14.26 / 16.1 Support & Resistance

Intellia Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

١٢ سبتمبر ٢٠٢٤، ٠٥:٠١ م UTC

Top News

The Brawl Taking Shape Over Pfizer's Multibillion-Dollar Heart Monopoly -- Heard on the Street -- Update

DJ

Read

١٢ سبتمبر ٢٠٢٤، ١١:٠٠ ص UTC

Top News

The Brawl Taking Shape Over Pfizer's Multibillion-Dollar Heart Monopoly -- Heard on the Street -- WSJ

DJ

Read

٨ يناير ٢٠٢٤، ١٢:٥٢ م UTC

Market Talk

Regeneron's 4Q Eylea Sales Look a Bit Light -- Market Talk

DJ

Read

Peer Comparison

Price change

Intellia Therapeutics Inc Forecast

Price Target

By TipRanks

260.35% upside

12 Months Forecast

Average 51.53 USD  260.35%

High 91 USD

Low 14 USD

Based on 22 Wall Street analysts offering 12 month price targets forIntellia Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

22 ratings

17

Buy

5

Hold

0

Sell

Based on 22 analysts giving stock ratings to Intellia Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

14.26 / 16.1Support & Resistance

Short Term

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Bearish Evidence

All events are bearish.

Long Term

Bearish Evidence

All events are bearish.

Sentiment

By Acuity

176 / 392 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

$

Other stocks from the sector

LLY

Eli Lilly and Co.

747.85

↓-0.07%

UNH

UnitedHealth Group Inc

590.82

↓-1.04%

JNJ

Johnson and Johnson

155.2

↓-0.15%

NVO

Novo Nordisk A-S

105.18

↑ +2.52%

ABBV

AbbVie Inc

177.14

↑ +3.17%